[
  {
    "id": 1,
    "year": "1998 – 2001*",
    "tx": "Arsenic trioxide",
    "biomarker": "PML-RARɑ Fusion",
    "biomarkerDetection": "DNA/NGS-based detection or FISH",
    "drugClassification": "Follow-on"
  },
  {
    "id": 2,
    "year": "1998 – 2001*",
    "tx": "Denileukin diftitox",
    "biomarker": "CD25+",
    "biomarkerDetection": "IHC",
    "drugClassification": "NA"
  },
  {
    "id": 3,
    "year": "1998 – 2001*",
    "tx": "Exemestane",
    "biomarker": "ER+",
    "biomarkerDetection": "IHC",
    "drugClassification": "NA"
  },
  {
    "id": 4,
    "year": "1998 – 2001*",
    "tx": "Gemtuzumab ozogamicin",
    "biomarker": "CD33+",
    "biomarkerDetection": "Flow cytometry",
    "drugClassification": "NA"
  },
  {
    "id": 5,
    "year": "1998 – 2001*",
    "tx": "Imatinib",
    "biomarker": "BCR-ABL1 Fusion (Ph+)",
    "biomarkerDetection": "DNA/NGS-based detection or FISH",
    "drugClassification": "First-in-class"
  },
  {
    "id": 6,
    "year": "1999 – 2001*",
    "tx": "Imatinib",
    "biomarker": "KIT+",
    "biomarkerDetection": "IHC; DNA/NGS-based detection can be used",
    "drugClassification": "First-in-class"
  },
  {
    "id": 7,
    "year": "2000 – 2001*",
    "tx": "Imatinib",
    "biomarker": "PDGFRA/B Fusions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 8,
    "year": "2001 – 2001*",
    "tx": "Imatinib",
    "biomarker": "PDGFB Fusions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 9,
    "year": "2002 – 2001*",
    "tx": "Imatinib",
    "biomarker": "FIP1L1-PDGFRA Fusion",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 10,
    "year": "1998 – 2001*",
    "tx": "Trastuzumab",
    "biomarker": "HER2+",
    "biomarkerDetection": "DNA/NGS-based detection, IHC, FISH or CISH",
    "drugClassification": "First-in-class"
  },
  {
    "id": 11,
    "year": "2002",
    "tx": "Fulvestrant",
    "biomarker": "HR+/ HER2-",
    "biomarkerDetection": "IHC",
    "drugClassification": "NA"
  },
  {
    "id": 12,
    "year": "2003",
    "tx": "Gefitinib",
    "biomarker": "EGFR L858R and exon 19 deletions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Follow-on"
  },
  {
    "id": 13,
    "year": "2003",
    "tx": "Tositumomab and Iodine I 131 Tositumomab",
    "biomarker": "CD20+",
    "biomarkerDetection": "Flow cytometry",
    "drugClassification": "NA"
  },
  {
    "id": 14,
    "year": "2004",
    "tx": "Cetuximab",
    "biomarker": "KRAS wildtype, EGFR-expressing",
    "biomarkerDetection": "DNA/NGS-based detection, IHC",
    "drugClassification": "First-in-class"
  },
  {
    "id": 15,
    "year": "2004",
    "tx": "Erlotinib",
    "biomarker": "EGFR L858R and exon 19 deletions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 16,
    "year": "2006",
    "tx": "Dasatinib",
    "biomarker": "BCR-ABL1 Fusion",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Resistance"
  },
  {
    "id": 17,
    "year": "2006",
    "tx": "Panitumumab",
    "biomarker": "KRAS and NRAS Wildtype, EGFR-expressing",
    "biomarkerDetection": "DNA/NGS-based detection, IHC",
    "drugClassification": "Follow-on"
  },
  {
    "id": 18,
    "year": "2006",
    "tx": "Sunitinib",
    "biomarker": "KIT+",
    "biomarkerDetection": "IHC; DNA/NGS-based detection can be used",
    "drugClassification": "Resistance"
  },
  {
    "id": 19,
    "year": "2007",
    "tx": "Lapatinib",
    "biomarker": "HER2 overexpression",
    "biomarkerDetection": "DNA/NGS-based detection, IHC or FISH",
    "drugClassification": "Mechanistically-distinct"
  },
  {
    "id": 20,
    "year": "2007",
    "tx": "Nilotinib",
    "biomarker": "BCR-ABL1 Fusion (Ph+)",
    "biomarkerDetection": "DNA/NGS-based detection or FISH",
    "drugClassification": "Resistance"
  },
  {
    "id": 21,
    "year": "2009",
    "tx": "Everolimus",
    "biomarker": "TSC1/2 Oncogenic Mutations",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 22,
    "year": "2011",
    "tx": "Brentuximab",
    "biomarker": "CD30+",
    "biomarkerDetection": "Flow cytometry",
    "drugClassification": "NA"
  },
  {
    "id": 23,
    "year": "2011",
    "tx": "Crizotinib",
    "biomarker": "ALK+ (ALK Fusions)",
    "biomarkerDetection": "DNA/NGS-based detection, IHC or FISH",
    "drugClassification": "First-in-class"
  },
  {
    "id": 24,
    "year": "2011",
    "tx": "Crizotinib",
    "biomarker": "ROS1+ (ROS1 Fusions)",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 25,
    "year": "2011",
    "tx": "Vemurafenib",
    "biomarker": "BRAF V600",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 26,
    "year": "2012",
    "tx": "Bosutinib",
    "biomarker": "BCR-ABL1 Fusion (Ph+)",
    "biomarkerDetection": "DNA/NGS-based detection or FISH",
    "drugClassification": "Resistance"
  },
  {
    "id": 27,
    "year": "2012",
    "tx": "Pertuzumab + Trastuzumab",
    "biomarker": "HER2+",
    "biomarkerDetection": "DNA/NGS-based detection, IHC or FISH",
    "drugClassification": "Mechanistically-distinct"
  },
  {
    "id": 28,
    "year": "2012",
    "tx": "Ponatinib",
    "biomarker": "BCR-ABL1 Fusion (Ph+)",
    "biomarkerDetection": "DNA/NGS-based detection or FISH",
    "drugClassification": "Mechanistically-distinct"
  },
  {
    "id": 29,
    "year": "2012",
    "tx": "Ponatinib",
    "biomarker": "ABL1 T315I",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Mechanistically-distinct"
  },
  {
    "id": 30,
    "year": "2012",
    "tx": "Regorafenib",
    "biomarker": "KIT+",
    "biomarkerDetection": "IHC; DNA/NGS-based detection can be used",
    "drugClassification": "Resistance"
  },
  {
    "id": 31,
    "year": "2013",
    "tx": "Ado-trastuzumab emtansine",
    "biomarker": "HER2+",
    "biomarkerDetection": "DNA/NGS-based detection, IHC, ISH or FISH",
    "drugClassification": "Follow-on"
  },
  {
    "id": 32,
    "year": "2013",
    "tx": "Afatinib",
    "biomarker": "EGFR L858R, G719X, L861Q, S768I, exon 19 deletions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Mechanistically-distinct"
  },
  {
    "id": 33,
    "year": "2013",
    "tx": "Dabrafenib",
    "biomarker": "BRAF V600E/K",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Follow-on"
  },
  {
    "id": 34,
    "year": "2013",
    "tx": "Ibrutinib",
    "biomarker": "17p del",
    "biomarkerDetection": "FISH",
    "drugClassification": "NA"
  },
  {
    "id": 35,
    "year": "2013",
    "tx": "Trametinib",
    "biomarker": "BRAF V600E/K",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 36,
    "year": "2014",
    "tx": "Blinatumomab",
    "biomarker": "CD19+",
    "biomarkerDetection": "Flow cytometry",
    "drugClassification": "NA"
  },
  {
    "id": 37,
    "year": "2014",
    "tx": "Ceritinib",
    "biomarker": "ALK+ (ALK Fusions)",
    "biomarkerDetection": "DNA/NGS-based detection or IHC",
    "drugClassification": "Resistance"
  },
  {
    "id": 38,
    "year": "2014",
    "tx": "Dabrafenib +Trametinib",
    "biomarker": "BRAF V600E/K",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 39,
    "year": "2014",
    "tx": "Nivolumab",
    "biomarker": "MSI-H",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Follow-on"
  },
  {
    "id": 40,
    "year": "2014",
    "tx": "Olaparib",
    "biomarker": "BRCA1/2 Oncogenic Mutations",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 41,
    "year": "2014",
    "tx": "Olaparib",
    "biomarker": "HRR Gene Oncogenic Mutations",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 42,
    "year": "2014",
    "tx": "Pembrolizumab",
    "biomarker": "MSI-H",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 43,
    "year": "2014",
    "tx": "Pembrolizumab",
    "biomarker": "TMB-H",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 44,
    "year": "2014",
    "tx": "Pembrolizumab",
    "biomarker": "PD-L1 expression",
    "biomarkerDetection": "IHC",
    "drugClassification": "First-in-class"
  },
  {
    "id": 45,
    "year": "2014",
    "tx": "Pembrolizumab",
    "biomarker": "dMMR",
    "biomarkerDetection": "IHC",
    "drugClassification": "First-in-class"
  },
  {
    "id": 46,
    "year": "2014",
    "tx": "Pembrolizumab",
    "biomarker": "pMMR",
    "biomarkerDetection": "IHC",
    "drugClassification": "First-in-class"
  },
  {
    "id": 47,
    "year": "2015",
    "tx": "Alectinib",
    "biomarker": "ALK+ (ALK Fusions)",
    "biomarkerDetection": "DNA/NGS-based detection, IHC",
    "drugClassification": "Resistance"
  },
  {
    "id": 48,
    "year": "2015",
    "tx": "Cobimetinib + Vemurafenib",
    "biomarker": "BRAF V600E/K",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Follow-on"
  },
  {
    "id": 49,
    "year": "2015",
    "tx": "Ipilimumab + Nivolumab",
    "biomarker": "MSI-H",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 50,
    "year": "2015",
    "tx": "Ipilimumab + Nivolumab",
    "biomarker": "dMMR",
    "biomarkerDetection": "IHC",
    "drugClassification": "First-in-class"
  },
  {
    "id": 51,
    "year": "2015",
    "tx": "Ipilimumab + Nivolumab",
    "biomarker": "PD-L1 expressing",
    "biomarkerDetection": "IHC",
    "drugClassification": "First-in-class"
  },
  {
    "id": 52,
    "year": "2015",
    "tx": "Osimertinib",
    "biomarker": "EGFR T790M, L858R and exon 19 deletions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Mechanistically-distinct"
  },
  {
    "id": 53,
    "year": "2015",
    "tx": "Palbociclib",
    "biomarker": "HR+/ HER2-",
    "biomarkerDetection": "IHC",
    "drugClassification": "NA"
  },
  {
    "id": 54,
    "year": "2016",
    "tx": "Atezolizumab",
    "biomarker": "PD-L1 expressing",
    "biomarkerDetection": "IHC",
    "drugClassification": "NA"
  },
  {
    "id": 55,
    "year": "2016",
    "tx": "Rucaparib",
    "biomarker": "BRCA1/2 Oncogenic Mutations",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Follow-on"
  },
  {
    "id": 56,
    "year": "2017",
    "tx": "Abemaciclib",
    "biomarker": "HR+/ HER2-",
    "biomarkerDetection": "IHC",
    "drugClassification": "NA"
  },
  {
    "id": 57,
    "year": "2017",
    "tx": "Brigatinib",
    "biomarker": "ALK+ (ALK Fusions)",
    "biomarkerDetection": "FISH; DNA/NGS-based detection can be used",
    "drugClassification": "Resistance"
  },
  {
    "id": 58,
    "year": "2017",
    "tx": "Enasidenib",
    "biomarker": "IDH2 R140, R172",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 59,
    "year": "2017",
    "tx": "Midostaurin",
    "biomarker": "FLT3 I836, 572_630ins, D835",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 60,
    "year": "2017",
    "tx": "Neratinib",
    "biomarker": "HER2+",
    "biomarkerDetection": "IHC; DNA/NGS-based detection can be used",
    "drugClassification": "Mechanistically-distinct"
  },
  {
    "id": 61,
    "year": "2017",
    "tx": "Niraparib",
    "biomarker": "BRCA1/2 Oncogenic Mutations",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Follow-on"
  },
  {
    "id": 62,
    "year": "2017",
    "tx": "Ribociclib",
    "biomarker": "HR+/ HER2-",
    "biomarkerDetection": "IHC",
    "drugClassification": "NA"
  },
  {
    "id": 63,
    "year": "2018",
    "tx": "Binimetinib + Encorafenib",
    "biomarker": "BRAF V600E/K",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Follow-on"
  },
  {
    "id": 64,
    "year": "2018",
    "tx": "Cemiplimab",
    "biomarker": "PD-L1 expression",
    "biomarkerDetection": "IHC",
    "drugClassification": "NA"
  },
  {
    "id": 65,
    "year": "2018",
    "tx": "Dacomitinib",
    "biomarker": "EGFR L858R and exon 19 deletions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Follow-on"
  },
  {
    "id": 66,
    "year": "2018",
    "tx": "Gilteritinib",
    "biomarker": "FLT3 I836, 572_630ins, D835",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Follow-on"
  },
  {
    "id": 67,
    "year": "2018",
    "tx": "Ivosidenib",
    "biomarker": "IDH1 R132",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 68,
    "year": "2018",
    "tx": "Larotrectinib",
    "biomarker": "NTRK1/2/3 Fusions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 69,
    "year": "2018",
    "tx": "Lorlatinib",
    "biomarker": "ALK+ (ALK Fusions)",
    "biomarkerDetection": "IHC; DNA/NGS-based detection can be used",
    "drugClassification": "Resistance"
  },
  {
    "id": 70,
    "year": "2018",
    "tx": "Lutetium Lu 177 dotatate",
    "biomarker": "Somatostatin receptor",
    "biomarkerDetection": "Radionucleotide scan",
    "drugClassification": "NA"
  },
  {
    "id": 71,
    "year": "2018",
    "tx": "Talazoparib",
    "biomarker": "BRCA1/2 Oncogenic Mutations",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Follow-on"
  },
  {
    "id": 72,
    "year": "2019",
    "tx": "Alpelisib + Fulvestrant",
    "biomarker": "PIK3CA E545G, Q546E, E545A, H1047R, C420R, H1047Y, Q546R, H1047L, E542K, E545D, E545K",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 73,
    "year": "2019",
    "tx": "Entrectinib",
    "biomarker": "NTRK1/2/3 Fusions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Follow-on"
  },
  {
    "id": 74,
    "year": "2019",
    "tx": "Entrectinib",
    "biomarker": "ROS1 Fusions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Follow-on"
  },
  {
    "id": 75,
    "year": "2019",
    "tx": "Erdafitinib",
    "biomarker": "FGFR2 Fusions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 76,
    "year": "2019",
    "tx": "Erdafitinib",
    "biomarker": "FGFR3 Fusions, S249C, R248C, G370C, Y373C",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 77,
    "year": "2019",
    "tx": "Trastuzumab Deruxtecan",
    "biomarker": "HER2+",
    "biomarkerDetection": "IHC; DNA/NGS-based detection can be used",
    "drugClassification": "First-in-class"
  },
  {
    "id": 78,
    "year": "2019",
    "tx": "Trastuzumab Deruxtecan",
    "biomarker": "HER2-low",
    "biomarkerDetection": "IHC",
    "drugClassification": "First-in-class"
  },
  {
    "id": 79,
    "year": "2019",
    "tx": "Trastuzumab Deruxtecan",
    "biomarker": "ERBB2 Oncogenic Mutations",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 80,
    "year": "2020",
    "tx": "Atezolizumab + Vemurafenib + Cobimetinib",
    "biomarker": "BRAF V600",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 81,
    "year": "2020",
    "tx": "Avapritinib",
    "biomarker": "PDGFRA Exon 18 mutations",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 82,
    "year": "2020",
    "tx": "Avapritinib",
    "biomarker": "KIT D816",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 83,
    "year": "2020",
    "tx": "Capmatinib",
    "biomarker": "MET Exon 14 skipping mutations",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 84,
    "year": "2020",
    "tx": "Encorafenib + Cetuximab",
    "biomarker": "BRAF V600E",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 85,
    "year": "2020",
    "tx": "Margetuximab",
    "biomarker": "HER2+",
    "biomarkerDetection": "IHC; DNA/NGS-based detection can be used",
    "drugClassification": "Follow-on"
  },
  {
    "id": 86,
    "year": "2020",
    "tx": "Pemigatinib",
    "biomarker": "FGFR2 Fusions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Follow-on"
  },
  {
    "id": 87,
    "year": "2020",
    "tx": "Pemigatinib",
    "biomarker": "FGFR1 Fusions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Follow-on"
  },
  {
    "id": 88,
    "year": "2020",
    "tx": "Pralsetinib",
    "biomarker": "RET Fusions and Oncogenic Mutations",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 89,
    "year": "2020",
    "tx": "Ripretinib",
    "biomarker": "KIT+",
    "biomarkerDetection": "IHC; DNA/NGS-based detection can be used",
    "drugClassification": "Mechanistically-distinct"
  },
  {
    "id": 90,
    "year": "2020",
    "tx": "Selpercatinib",
    "biomarker": "RET Fusions and Oncogenic Mutations",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 91,
    "year": "2020",
    "tx": "Selumetinib",
    "biomarker": "NF1 Oncogenic Mutations",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 92,
    "year": "2020",
    "tx": "Tazemetostat",
    "biomarker": "EZH2 Y646F, A692V, Y646C, Y646S, Y646N, Y646H, A682G",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 93,
    "year": "2020",
    "tx": "Tazemetostat",
    "biomarker": "SMARCB1 Deletion",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 94,
    "year": "2020",
    "tx": "Tucatinib + Trastuzumab",
    "biomarker": "HER2+",
    "biomarkerDetection": "IHC; DNA/NGS-based detection can be used",
    "drugClassification": "Follow-on"
  },
  {
    "id": 95,
    "year": "2021",
    "tx": "Amivantamab",
    "biomarker": "EGFR Exon 20 insertions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 96,
    "year": "2021",
    "tx": "Asciminib",
    "biomarker": "BCR-ABL1 Fusion and ABL1 T315I",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Resistance"
  },
  {
    "id": 97,
    "year": "2021",
    "tx": "Belzutifan",
    "biomarker": "VHL Oncogenic Mutations",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 98,
    "year": "2021",
    "tx": "Dostarlimab",
    "biomarker": "dMMR",
    "biomarkerDetection": "IHC",
    "drugClassification": "NA"
  },
  {
    "id": 99,
    "year": "2021",
    "tx": "Infigratinib",
    "biomarker": "FGFR2 Fusions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Follow-on"
  },
  {
    "id": 100,
    "year": "2021",
    "tx": "Mobocertinib",
    "biomarker": "EGFR Exon 20 insertions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 101,
    "year": "2021",
    "tx": "Sotorasib",
    "biomarker": "KRAS G12C",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 102,
    "year": "2021",
    "tx": "Tepotinib",
    "biomarker": "MET Exon 14 skipping mutations",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 103,
    "year": "2021",
    "tx": "Trastuzumab + Pembrolizumab",
    "biomarker": "HER2+",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "First-in-class"
  },
  {
    "id": 104,
    "year": "2022",
    "tx": "Futibatinib",
    "biomarker": "FGFR2 Fusions",
    "biomarkerDetection": "DNA/NGS-based detection",
    "drugClassification": "Follow-on"
  },
  {
    "id": 105,
    "year": "2022",
    "tx": "Pluvicto",
    "biomarker": "PMSA+",
    "biomarkerDetection": "IHC or PET imaging",
    "drugClassification": "NA"
  },
  {
    "id": 106,
    "year": "2022",
    "tx": "Tebentafusp",
    "biomarker": "HLA-A*02:01-positivity",
    "biomarkerDetection": "DNA; HLA-typing",
    "drugClassification": "NA"
  }
]
